OverviewSuggest Edit

    Alcami is a contract development and manufacturing organization. It offers services across active pharmaceutical ingredients (APIs), solid-state chemistry, formulation development, analytical testing, and packaging.
    HQWilmington, NC, US
    Employee Ratings3.9

    Latest Updates

    Employees (est.) (Feb 2020)900
    Cybersecurity ratingBMore

    Key People/Management at Alcami

    Eric Evans

    Eric Evans

    Chief Finance Officer
    Jacquelyn Uribe

    Jacquelyn Uribe

    Vice President of Quality Operations
    Ken Domagalski

    Ken Domagalski

    EVP of Drug Product Operations
    Elliott Franco

    Elliott Franco

    VP of Laboratory Operations
    Sally Langa

    Sally Langa

    SVP of Commercial Operations
    Kimberly McClintock

    Kimberly McClintock

    Vice President of Project Management
    Show more

    Alcami Office Locations

    Alcami has offices in Wilmington, Durham, Germantown, Morrisville and in 3 other locations
    Wilmington, NC, US (HQ)
    2320 Scientific Park Dr
    Durham, NC, US
    4620 Creekstone Dr #200
    Germantown, WI, US
    10550 Grant Dr w132
    Morrisville, NC, US
    627 Davis Dr #100
    North Charleston, SC, US
    4221 Faber Pl Dr
    St. Louis, MO, US
    4260 Forest Park Ave #201
    Show all (7)

    Alcami Financials and Metrics

    Summary Metrics

    Founding Date


    Alcami Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    Alcami Online and Social Media Presence

    Embed Graph

    Alcami News and Updates

    Clinical Trial Market Revenue to Cross $69.94 by 2027 Global Industry Size, Share, Trends, COVID-19 Analysis and Technology Advancements by Clinipace, Novo Nordisk, Pfizer, Sanofi, F. Hoffmann-La Roche Ltd, Alcami Corporation and Accell Clinical Research

    SAN FRANCISCO, April 22, 2021 (GLOBE NEWSWIRE) -- Data Bridge Market Research has recently published the Global Clinical Trials Market the study provides an overview of current statistics and future predictions of the Global Clinical Trials Market. The study highlights a detailed assessment of the…

    Alcami Expands Oral Solid Capabilities with Investment in Wilmington

    WILMINGTON, N.C., Jan. 7, 2021 /PRNewswire/ -- Alcami, a leading United States-based contract development and manufacturing organization (CDMO), announced an additional $2 million investment to expand its oral solid development and manufacturing capabilities in Wilmington, NC. The...

    Alcami Providing Commercial Manufacturing for Trevena's Recently FDA Approved OLINVYK™

    WILMINGTON, N.C., Aug. 26, 2020 /PRNewswire/ -- Alcami, a US-based contract development and manufacturing organization (CDMO), announced today that it is providing commercial manufacturing services for Trevena's newly approved OLINVYK. OLINVYK (oliceridine) injection is an opioid approved...

    Alcami Continues to Strengthen Senior Leadership Team with Appointment of Quality and Regulatory Leaders

    WILMINGTON, N.C., May 21, 2020 /PRNewswire/ -- Alcami, a North Carolina-based contract development and manufacturing organization (CDMO), today announced further additions to strengthen its senior leadership team. Brian Dillion has been appointed to the role of Vice President of...

    Alcami Blogs

    White Paper: Host Cell Impurities, Bioassays, Micro-Flow Imaging

    As opposed to traditional drug production, the production of biological products (biologics) requires the involvement of human, animal, or microbial cells. Biologics are some of the most effective and cutting-edge therapeutics, such as vaccines and antibodies produced through recombinant protein tec…

    QbD Addresses API Supply in Orphan Drug Formulation

    According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or …

    Tryp Therapeutics Partners with Alcami for Proprietary Formulations

    The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s Psilocybin-For-Neuropsychiatric Disorder (PFNTM) program

    Lab Open House - May 11

    From standalone projects through full-service programs, our laboratories provide solutions to your most complex challenges. Reserve your seat at our virtual laboratory open house to hear first-hand from our lab leadership team how Alcami is poised for customer satisfaction and the future…
    Show more

    Alcami Frequently Asked Questions

    • When was Alcami founded?

      Alcami was founded in 2016.

    • Who are Alcami key executives?

      Alcami's key executives are Eric Evans, Jacquelyn Uribe and Ken Domagalski.

    • How many employees does Alcami have?

      Alcami has 900 employees.

    • Who are Alcami competitors?

      Competitors of Alcami include Cyprotex, Saneca Pharma and NextPharma.

    • Where is Alcami headquarters?

      Alcami headquarters is located at 2320 Scientific Park Dr, Wilmington.

    • Where are Alcami offices?

      Alcami has offices in Wilmington, Durham, Germantown, Morrisville and in 3 other locations.

    • How many offices does Alcami have?

      Alcami has 7 offices.